TLPH Q2 2022 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q2 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$570,000+28.7% YoY

Gross Profit

-$306,000-53.7% margin

Operating Income

-$9M-1521.4% margin

Net Income

$71M12397.0% margin

EPS (Diluted)

$9.60

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$753,000

Balance Sheet

Total Assets

$56M

Total Liabilities

$23M

Stockholders' Equity

$33M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$570,000	$443,000	+28.7%
Gross Profit	-$306,000	-$597,000	+48.7%
Operating Income	-$9M	-$10M	+13.4%
Net Income	$71M	-$10M	+817.3%